These results suggested the METTL3 was involved in the tumor immune escape by upregulation of PD-L1 expression which inhibited intertumoral T-cell infiltration; tumoral METTL3 deficiency showed similar responses to those upon PD-L1 blockade treatment. This evidence concerns the gene CD274 and neoplasm.